Diagnostic Products Corporation adds Axis-Shield's anti-CCP test for rheumatoid arthritis to Immulite menu:
This article was originally published in Clinica
Executive Summary
Anglo-Norwegian IVD company Axis-Shield has agreed to license its anti-CCP test to Diagnostic Products Corporation (DPC) for use on the latter's Immulite chemiluminescent analyser to detect rheumatoid arthritis. Financial details of the agreement were not disclosed. The anti-CCP assay is considered to be the most significant breakthrough in the early diagnosis of rheumatoid arthritis, a condition that affects over 2 million people in the US alone, said Axis-Shield.